Cortical lesions at diagnosis predict long‐term cognitive impairment in multiple sclerosis: A 20‐year study

Although cognitive impairment (CI) is frequent in multiple sclerosis (MS) patients, few studies (and with conflicting results) have evaluated early predictors of CI in the long term. We aimed at determining associations between early clinical/neuroradiological variables with reference to CI after 20 years of MS.

[1]  M. Filippi,et al.  A Deep Learning Approach to Predicting Disease Progression in Multiple Sclerosis Using Magnetic Resonance Imaging , 2022, Investigative radiology.

[2]  I. Pulido-Valdeolivas,et al.  Dynamics and Predictors of Cognitive Impairment along the Disease Course in Multiple Sclerosis , 2021, Journal of personalized medicine.

[3]  M. Calabrese,et al.  Cerebrospinal fluid inflammatory profile of cognitive impairment in newly diagnosed multiple sclerosis patients , 2021, Multiple sclerosis.

[4]  O. Ciccarelli,et al.  Cortical involvement determines impairment 30 years after a clinically isolated syndrome , 2021, Brain : a journal of neurology.

[5]  C. Mainero,et al.  The relevance of multiple sclerosis cortical lesions on cortical thinning and their clinical impact as assessed by 7.0-T MRI , 2021, Journal of Neurology.

[6]  Turi O. Dalaker,et al.  Brain atrophy and clinical characteristics predicting SDMT performance in multiple sclerosis: A 10-year follow-up study , 2021, Multiple sclerosis journal - experimental, translational and clinical.

[7]  M. Amato,et al.  Understanding the pathophysiology of cognitive changes in MS: A step forward , 2020, Multiple Sclerosis.

[8]  J. DeLuca,et al.  Cognitive impairment in multiple sclerosis: clinical management, MRI, and therapeutic avenues , 2020, The Lancet Neurology.

[9]  Christian Gaser,et al.  Cognitive impairment in early MS: contribution of white matter lesions, deep grey matter atrophy, and cortical atrophy , 2020, Journal of Neurology.

[10]  O. Ciccarelli,et al.  Early imaging predictors of long-term outcomes in relapse-onset multiple sclerosis. , 2019, Brain : a journal of neurology.

[11]  O. Ciccarelli,et al.  Assessment of lesions on magnetic resonance imaging in multiple sclerosis: practical guidelines , 2019, Brain : a journal of neurology.

[12]  P. Calabresi,et al.  Multiple sclerosis and cognition: synaptic failure and network dysfunction , 2018, Nature Reviews Neuroscience.

[13]  F. Barkhof,et al.  Predicting cognitive decline in multiple sclerosis: a 5-year follow-up study , 2018, Brain : a journal of neurology.

[14]  G. Crisi,et al.  Correlation between cortical lesions and cognitive impairment in multiple sclerosis , 2018, Brain and behavior.

[15]  David H. Miller,et al.  Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria , 2017, The Lancet Neurology.

[16]  P. Pasqualetti,et al.  Cognitive Impairment in Relapsing-Remitting Multiple Sclerosis Patients with Very Mild Clinical Disability , 2017, Behavioural neurology.

[17]  F. Paul,et al.  Pathology and MRI: exploring cognitive impairment in MS , 2016, Acta neurologica Scandinavica.

[18]  G Tedeschi,et al.  Regional cortical thinning in multiple sclerosis and its relation with cognitive impairment: A multicenter study , 2016, Multiple sclerosis.

[19]  David H. Miller,et al.  A longitudinal study of cortical grey matter lesion subtypes in relapse-onset multiple sclerosis , 2015, Journal of Neurology, Neurosurgery & Psychiatry.

[20]  G. Altoé,et al.  The Italian version of the Depression Anxiety Stress Scales-21: Factor structure and psychometric properties on community and clinical samples. , 2015, Comprehensive psychiatry.

[21]  À. Rovira,et al.  Defining high, medium and low impact prognostic factors for developing multiple sclerosis. , 2015, Brain : a journal of neurology.

[22]  Massimo Filippi,et al.  Clinical and imaging assessment of cognitive dysfunction in multiple sclerosis , 2015, The Lancet Neurology.

[23]  Hirofumi Ochi,et al.  [Cognitive impairment in multiple sclerosis]. , 2014, Brain and nerve = Shinkei kenkyu no shinpo.

[24]  Alan J. Thompson,et al.  Atlas of Multiple Sclerosis 2013: A growing global problem with widespread inequity , 2014, Neurology.

[25]  M. Horsfield,et al.  Gray matter damage predicts the accumulation of disability 13 years later in MS , 2013, Neurology.

[26]  Chiara Romualdi,et al.  The changing clinical course of multiple sclerosis: A matter of gray matter , 2013, Annals of neurology.

[27]  A. Gass,et al.  Contribution of cortical and white matter lesions to cognitive impairment in multiple sclerosis , 2013, Multiple sclerosis.

[28]  Massimiliano Calabrese,et al.  Measurement and clinical effect of grey matter pathology in multiple sclerosis , 2012, The Lancet Neurology.

[29]  M. Calabrese,et al.  Cortical lesion load associates with progression of disability in multiple sclerosis. , 2012, Brain : a journal of neurology.

[30]  F. Barkhof,et al.  Imaging the tip of the iceberg: visualization of cortical lesions in multiple sclerosis , 2011, Multiple sclerosis.

[31]  O. Ciccarelli,et al.  Consensus recommendations for MS cortical lesion scoring using double inversion recovery MRI , 2011, Neurology.

[32]  M. Calabrese,et al.  Widespread cortical thinning characterizes patients with MS with mild cognitive impairment , 2010, Neurology.

[33]  Massimo Filippi,et al.  Cortical lesions and atrophy associated with cognitive impairment in relapsing-remitting multiple sclerosis. , 2009, Archives of neurology.

[34]  F. Barkhof,et al.  Accumulation of cortical lesions in MS: relation with cognitive impairment , 2009, Multiple sclerosis.

[35]  J. Lowe,et al.  Regional variations in the extent and pattern of grey matter demyelination in multiple sclerosis: a comparison between the cerebral cortex, cerebellar cortex, deep grey matter nuclei and the spinal cord , 2008, Journal of Neurology, Neurosurgery, and Psychiatry.

[36]  M. Ron,et al.  Cognitive impairment in multiple sclerosis can be predicted by imaging early in the disease , 2008, Journal of Neurology, Neurosurgery, and Psychiatry.

[37]  Chiara Romualdi,et al.  Detection of cortical inflammatory lesions by double inversion recovery magnetic resonance imaging in patients with multiple sclerosis. , 2007, Archives of neurology.

[38]  Hans Lassmann,et al.  Widespread Demyelination in the Cerebellar Cortex in Multiple Sclerosis , 2007, Brain pathology.

[39]  S. Sorbi,et al.  The Rao’s Brief Repeatable Battery and Stroop test: normative values with age, education and gender corrections in an Italian population , 2006, Multiple sclerosis.

[40]  P. M. Matthews,et al.  Evidence of early cortical atrophy in MS , 2003, Neurology.

[41]  Paolo Caffarra,et al.  Una versione abbreviata del test di Stroop: dati normativi nella popolazione italiana , 2002 .

[42]  A. Compston,et al.  Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis , 2001, Annals of neurology.

[43]  R. Kikinis,et al.  Regional magnetic resonance imaging lesion burden and cognitive function in multiple sclerosis: a longitudinal study. , 2001, Archives of neurology.

[44]  Jerry L Prince,et al.  Current methods in medical image segmentation. , 2000, Annual review of biomedical engineering.

[45]  A. Thompson,et al.  Magnetic resonance imaging in monitoring the treatment of multiple sclerosis: concerted action guidelines. , 1991, Journal of neurology, neurosurgery, and psychiatry.

[46]  J. Kurtzke.  Rating neurologic impairment in multiple sclerosis , 1983, Neurology.

[47]  Stephen M. Rao,et al.  Cognition in multiple sclerosis State of the fi eld and priorities for the future , 2022 .